GlassScriptPhysician profile
William Thompson
NPI 1881670727
$12,912.95
in general payments reported to CMS, 2019-2025
72 companies · $2,296 in 2025
The $2,296 reported for 2025 was more than what 95% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,096 · 2020: $764 · 2021: $1,277 · 2022: $1,856 · 2023: $1,350 · 2024: $3,275 · 2025: $2,296.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,349 · Travel and Lodging: $562 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,349.40 |
| Travel and Lodging | $562.02 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $1,639.00 | 2021-2025 | Phasix Mesh |
| Intuitive Surgical, INC. | $1,334.75 | 2022-2024 | |
| Medical Device Business Services, INC. | $999.70 | 2019 | |
| Abbvie INC. | $666.23 | 2019-2025 | Creon |
| Merck Sharp & Dohme LLC | $543.48 | 2019-2025 | Keytruda, Lynparza, Keytruda Qlex |
| Janssen Biotech, INC. | $456.53 | 2019-2025 | Darzalex, Talvey, Tecvayli |
| Astrazeneca Pharmaceuticals LP | $421.18 | 2019-2025 | Imfinzi, Calquence, Enhertu |
| Takeda Pharmaceuticals U.S.A., INC. | $399.29 | 2019-2025 | Ninlaro, Fruzaqla, Alunbrig |
| Novartis Pharmaceuticals Corporation | $389.32 | 2020-2025 | |
| Boston Scientific Corporation | $389.11 | 2019-2025 | Axios, Wavewriter Alpha Prime 16 |
| Amgen INC. | $383.39 | 2019-2023 | Kyprolis, Blincyto |
| Ethicon US, LLC | $347.61 | 2021-2025 | Echelon; Endopath, Harmonic, Enseal |
| Seagen INC. | $286.42 | 2019-2023 | Tukysa, Adcetris, Padcev |
| Genentech USA, INC. | $264.24 | 2024-2025 | Polivy, Lunsumio, Columvi |
| Angiodynamics, INC. | $248.79 | 2022-2025 | Nanoknife |
Show all 72 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tela Bio, INC. | $244.08 | 2020-2021 | |
| Octapharma USA, INC. | $225.75 | 2022-2025 | Octagam Immune Globulin (Human) |
| Bayer Healthcare Pharmaceuticals INC. | $215.13 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $192.86 | 2020-2025 | Opdivo, Opdualag, Augtyro |
| Daiichi Sankyo INC. | $183.05 | 2021-2025 | Enhertu, Datroway |
| Eisai INC. | $175.90 | 2019-2025 | |
| Wound Management Technologies, INC | $144.21 | 2019 | |
| Springworks Therapeutics, INC. | $142.98 | 2024-2025 | Ogsiveo |
| Alexion Pharmaceuticals, INC. | $142.82 | 2019-2024 | Soliris, Ultomiris |
| Incyte Corporation | $140.23 | 2019-2024 | Jakafi, Monjuvi, Pemazyre |
| Acell, INC. | $119.28 | 2020 | |
| Beone Medicines USA, INC. | $110.40 | 2025 | Brukinsa |
| Lilly USA, LLC | $108.37 | 2019-2023 | Jaypirca, Verzenio, Retevmo |
| Aveo Pharmaceuticals, INC. | $107.32 | 2023-2025 | Fotivda |
| Pfizer INC. | $104.67 | 2019-2025 | |
| Genzyme Corporation | $95.24 | 2019-2024 | |
| Regeneron Healthcare Solutions, INC. | $94.00 | 2019-2025 | Libtayo |
| Blueprint Medicines Corporation | $93.93 | 2023-2025 | Ayvakit |
| Glaxosmithkline, LLC. | $90.90 | 2022-2024 | Ojjaara, Jemperli |
| Pharmacyclics LLC, An Abbvie Company | $90.36 | 2019-2022 | |
| Sobi, INC | $79.61 | 2022-2024 | |
| Osiris Therapeutics INC. | $78.68 | 2019 | |
| Exelixis INC. | $72.36 | 2019-2024 | Cabometyx |
| Myriad Genetic Laboratories, INC. | $71.25 | 2021-2024 | Myrisk, Precisetumor |
| Taiho Oncology, INC. | $68.10 | 2020-2023 | |
| Csl Behring | $61.28 | 2024-2025 | Hizentra |
| Medtronic, INC. | $59.33 | 2022-2023 | Signia |
| Ipsen Biopharmaceuticals, INC | $58.45 | 2020-2025 | Onivyde, Somatuline Depot |
| Sumitomo Pharma America, INC. | $46.58 | 2024-2025 | Orgovyx |
| Pharmacosmos Therapeutics INC. | $46.10 | 2022-2025 | Monoferric |
| Kci USA, INC. | $42.52 | 2022 | |
| Dova Pharmaceuticals | $42.35 | 2020-2021 | |
| Celgene Corporation | $40.91 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $40.66 | 2019-2025 | |
| Novocure INC. | $38.46 | 2025 | Optune Lua (Novottf-200t) |
| Immunogen, INC. | $36.60 | 2023-2024 | Elahere, Elahere |
| Rigel Pharmaceuticals, INC. | $32.89 | 2019-2023 | Tavalisse, Rezlidhia |
| Adaptive Biotechnologies Corporation | $32.20 | 2024-2025 | Clonoseq |
| Jazz Pharmaceuticals INC. | $31.38 | 2020-2021 | |
| Recordati_rare_diseases_inc. | $31.00 | 2025 | Sylvant |
| Karyopharm Therapeutics INC. | $29.07 | 2020-2021 | |
| Array Biopharma INC | $24.01 | 2019 | |
| Kite Pharma, INC. | $23.28 | 2025 | Yescarta |
| Stemline Therapeutics INC. | $22.39 | 2023 | Orserdu |
| Coherus Oncology, INC. | $21.51 | 2024 | |
| Telix Pharmaceuticals | $21.18 | 2023 | Illuccix |
| Servier Pharmaceuticals LLC | $20.49 | 2025 | |
| Deciphera Pharmaceuticals INC. | $19.20 | 2021 | |
| Conmed Corporation | $16.25 | 2019 | |
| Epizyme, INC. | $15.55 | 2022 | |
| Accord Healthcare, INC. | $15.50 | 2023 | |
| Tersera Therapeutics LLC | $15.11 | 2022 | |
| Helsinn Therapeutics (U.S.), INC. | $14.64 | 2019 | |
| Morphosys, US INC. | $14.44 | 2022 | |
| Clovis Oncology, INC. | $13.63 | 2019 | |
| Advanced Accelerator Applications | $13.00 | 2019 | |
| Secura Bio, INC. | $12.47 | 2020 |
Drugs and devices associated with these payments
Da Vinci Surgical System $1,309Phasix Mesh $605Keytruda $380Axios $264Octagam Immune Globulin (Human) $180Nanoknife $158Polivy $153Ninlaro $144Ogsiveo $143Strattice Reconstructive Tissue Matrix Bps $142Enseal $137Echelon; Endopath $137Harmonic $137Darzalex $133Imfinzi $128Enhertu $121Brukinsa $110Talvey $110Fotivda $107Kisqali $105Calquence $98.05Ayvakit $93.93Lynparza $90.85Tecvayli $90.62Lunsumio $82.97Columvi $82.97Creon $79.97Fruzaqla $79.92Elahere $78.86Rybrevant $72.24Sarclisa $71.69Phesgo $69.23Vistaseal $63.22Hizentra $61.28Tukysa $59.37Vitrakvi $58.30Stivarga $58.30Nubeqa $57.40Jakafi $53.36Opdivo $53.09Ojjaara $52.83Lenvima $52.68Monjuvi $52.22Opdualag $49.61Orgovyx $46.58Pluvicto $43.49Adcetris $43.06Libtayo $42.76Illuccix $42.36Jaypirca $41.69Retevmo $41.69Verzenio $41.69Doptelet $41.14Xofigo $40.55Cabometyx $39.10Optune Lua (Novottf-200t) $38.46Tivdak $34.98Piqray $34.77Padcev $34.68Clonoseq $32.20Sylvant $31.00Echelon Circular $28.54Evarrest $28.54Surgicel Nu-Knit $28.54Datroway $28.54Augtyro $27.99Keytruda Qlex $27.72Pemazyre $25.49Mekinist $25.26Inqovi $24.79Lonsurf $24.79Jemperli $24.07Yescarta $23.28Alunbrig $22.99Orserdu $22.39Monoferric $22.34Itovebi $22.10Soliris $22.01Somatuline Depot $21.78Onivyde $21.78Elrexfio $21.64Iclusig $21.61Udenyca $21.51Carvykti $21.24Voranigo $20.49Tecentriq $20.22Rezlidhia $19.75Tavalisse $19.75Welireg $19.31Scemblix $19.20Inlyta $18.77Erleada $18.62Myrisk $17.52Signia $16.91Kyprolis $16.78Blincyto $16.78Ultomiris $16.47Wavewriter Alpha Prime 16 $15.67Precisetumor $15.52Camcevi $15.50
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Thompson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.